Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML.
Deguchi
K
K
Howard Hughes Medical Institute, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA, USA.
Gilliland
D G
DG
D001853:Bone Marrow / Q000201:enzymology; D002454:Cell Differentiation / Q000235:genetics; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000378:metabolism*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics* / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000378:metabolism; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D015398:Signal Transduction; D014157:Transcription Factors / Q000235:genetics*; D014443:Tyrosine / Q000378:metabolism*
D015514:Oncogene Proteins, Fusion; D014157:Transcription Factors; D014443:Tyrosine; D011505:Protein-Tyrosine Kinases